阿德福韦混膦酯衍生物体外代谢及稳定性研究
In vitro metabolism and stability of adefovir mixed phosphonate derivative Q3-I2
-
摘要: 采用超高效液相-飞行时间质谱仪(UPLC-QTOF-MS/MS)和超高效液相-三重四极杆质谱仪(UPLC-MS/MS)考察阿德福韦混膦酯衍生物阿德福韦单L-硫代异亮氨酸乙酯、去氧胆酸丙酯(Q3-I2)的稳定性及体外代谢产物，将Q3-I2和对照药阿德福韦酯与人工胃液、人工肠液、大鼠空白血浆和大鼠肝微粒体进行体外共孵育，采用UPLC-MS/MS和UPLC-QTOF-MS分别测定各孵育体系中的化合物剩余质量浓度和肝微粒体体系中的代谢产物，并通过底物消除法计算半衰期和清除率。化合物Q3-I2在胃肠道中稳定，延长了血浆、肝微粒体半衰期，同时能降解出活性代谢产物。在体外肝微粒体孵育体系中通过UPLC-QTOF-MS正负离子模式共检测到8种代谢产物，主要包括水解、氧化、乙酰化、葡萄糖醛酸化反应。
-
关键词:
- 阿德福韦混膦酯 /
- 衍生物 /
- 代谢 /
- UPLC-QTOF-MS/MS /
- UPLC-MS/MS /
- 稳定性
Abstract: A, UPLC-QTOF-MS/MS and UPLC-MS/MS were used to investigate the derivative of adefovir mixed phosphonate Q3-I2. Stability and in vitro metabolites of Q3-I2, and the control drug adefovir dipivoxil were co-inculbated with artificial gastric juice, artificial intestinal juice, rat blank plasma and rat liver microsomes, using UPLC-MS/MS and UPLC-QTOF-MS/MS measure the residual concentration of the compounds in each incubation system and the metabolites in the liver microsomal system, respectively, and calculate the half-life and clearance rate by the substrate elimination method. The compounds designed and synthesized in this experiment are stable in the gastrointestinal tract, prolonging t1/2 of plasma and liver microsomes and rapidly degrading the active meta-bolites. In the liver microsomal system, a total of 8 metabolites were detected by positive and negative ion mode, including hydrolysis, oxidation, acetylation, and glucuronidation.-
Keywords:
- adefovir mixed phosphate /
- derivatives /
- metabolism /
- UPLC-QTOF-MS/MS /
- UPLC-MS/MS /
- stability
-
-
[1] Sweet DH,Bush KT,Nigam SK.The organic anion transporter family:from physiology to ontogeny and the clinic[J].Am J Physiol Renal Physiol,2001,281:197-205. [2] Xiang D,Zhang CL,Yu ZQ,et al.Research progress of bile acid transporters[J].J China Pharm Univ(中国药科大学学报),2017,52(3):567-573. [3] Enhsen A,Kramer W,Wess G.Bile acids in drug discovery[J].J Drug Discov Today,1998,3:409-418. [4] Su H,Chen Y,Fu XZ,et al.Synthesis,antiviral activity and primary hepatocyte uptake of adefovir single L-amino acid and bile acid ester derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(3):264-268. [5] Zhang WZ,Yang Y,Chen Y,et al.Synthesis and biological eva-luation of mixed phosphonates derivatives of adefovir with hepatotrophic property[J].J China Pharm Univ(中国药科大学学报),2018,49(1):39-47. [6] Haufroid V,Buchet JP,Gardinal S,et al.Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio:assessment of its usefulness in Workers Exposed To styrene[J].Int Arch Occup Environ Health,2002,75(7):453-458. [7] Mcfadyen MC,Breeman S,Payne S,et al.Immuno-histochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1[J].J Histochem Cytochem,1999,47(11):1457-1464. [8] Baranczewski P,Stanczak A,sundbergk,et al.Introduction to in vitro estimation of metabolic stability and drug interactions of vew chemical entities in drug discovery and development[J].J Pharacol Rep,2006,58(4):453-472. [9] Qin ZF,Li SS,Yao ZH,et al.Metabolic profiling of corylin in vivo and in vitro[J].J Pharm Biomed Anal,2018,15(5):157-168. [10] Ettmayer P,Amidon GL,Clement B,et al.Lessons learned from marketed and investigation pro-drugs[J].J Med Chem,2004,47(10):2393-2404.
计量
- 文章访问数: 543
- HTML全文浏览量: 0
- PDF下载量: 932
下载:
